Floatz logo

Aprotinin

Head And Neck Squamous Cell Carcinomas

Sun Yat-sen Universityprotein_peptidePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Head And Neck Squamous Cell Carcinomas cohort.

Asset / SponsorPhaseRating
Trilaciclib
Sun Yat-sen University
Phase 2CCC

Same molecule, other indications

Aprotinin is also rated in:

Breast CancerDormant
CCC
Indicative ·
50 / 100
View asset →
NSCLCDormant
CCC
Indicative ·
48 / 100
View asset →
Endometrial CancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →